MDMA, better known as the illegal drug Ecstasy, has shown promise for treating people with post-traumatic stress disorder. Now the FDA has granted the drug “breakthrough” status, and a phase 3 trial could begin as early as spring 2018.
from Lifehacker http://ift.tt/2vyM74F
http://ift.tt/2vyciZh